Correlation Between Merus BV and Cerevel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Merus BV and Cerevel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merus BV and Cerevel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merus BV and Cerevel Therapeutics Holdings, you can compare the effects of market volatilities on Merus BV and Cerevel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merus BV with a short position of Cerevel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merus BV and Cerevel Therapeutics.
Diversification Opportunities for Merus BV and Cerevel Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Merus and Cerevel is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Merus BV and Cerevel Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cerevel Therapeutics and Merus BV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merus BV are associated (or correlated) with Cerevel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cerevel Therapeutics has no effect on the direction of Merus BV i.e., Merus BV and Cerevel Therapeutics go up and down completely randomly.
Pair Corralation between Merus BV and Cerevel Therapeutics
If you would invest (100.00) in Cerevel Therapeutics Holdings on September 2, 2024 and sell it today you would earn a total of 100.00 from holding Cerevel Therapeutics Holdings or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 0.0% |
Values | Daily Returns |
Merus BV vs. Cerevel Therapeutics Holdings
Performance |
Timeline |
Merus BV |
Cerevel Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Merus BV and Cerevel Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Merus BV and Cerevel Therapeutics
The main advantage of trading using opposite Merus BV and Cerevel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merus BV position performs unexpectedly, Cerevel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerevel Therapeutics will offset losses from the drop in Cerevel Therapeutics' long position.Merus BV vs. Anebulo Pharmaceuticals | Merus BV vs. Adagene | Merus BV vs. Acrivon Therapeutics, Common | Merus BV vs. AnaptysBio |
Cerevel Therapeutics vs. Avidity Biosciences | Cerevel Therapeutics vs. Revolution Medicines | Cerevel Therapeutics vs. Day One Biopharmaceuticals | Cerevel Therapeutics vs. SpringWorks Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |